Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4217882
Max Phase: Preclinical
Molecular Formula: C46H71N9O9
Molecular Weight: 894.13
Molecule Type: Small molecule
Associated Items:
ID: ALA4217882
Max Phase: Preclinical
Molecular Formula: C46H71N9O9
Molecular Weight: 894.13
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N(C)C
Standard InChI: InChI=1S/C46H71N9O9/c1-10-28(6)39(52-42(60)38-18-14-20-55(38)45(63)34(22-27(4)5)48-29(7)57)43(61)51-36(25-56)40(58)49-35(23-30-24-47-32-16-12-11-15-31(30)32)46(64)54-19-13-17-37(54)41(59)50-33(21-26(2)3)44(62)53(8)9/h11-12,15-16,24,26-28,33-39,47,56H,10,13-14,17-23,25H2,1-9H3,(H,48,57)(H,49,58)(H,50,59)(H,51,61)(H,52,60)/t28-,33-,34-,35-,36-,37-,38-,39-/m0/s1
Standard InChI Key: GZSANHPVWZFCSI-PJKCPVONSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 894.13 | Molecular Weight (Monoisotopic): 893.5375 | AlogP: 1.36 | #Rotatable Bonds: 21 |
Polar Surface Area: 242.45 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.63 | CX Basic pKa: | CX LogP: 0.76 | CX LogD: 0.76 |
Aromatic Rings: 2 | Heavy Atoms: 64 | QED Weighted: 0.10 | Np Likeness Score: -0.20 |
1. Du L, Grigsby SM, Yao A, Chang Y, Johnson G, Sun H, Nikolovska-Coleska Z.. (2018) Peptidomimetics for Targeting Protein-Protein Interactions between DOT1L and MLL Oncofusion Proteins AF9 and ENL., 9 (9): [PMID:30258537] [10.1021/acsmedchemlett.8b00175] |
Source(1):